|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| 03-31 | Indivior Pharmaceuticals, Inc. Announces Findings From Cost Impact Model For Monthly Injectable Buprenorphine | CI |
| 03-23 | Top Premarket Gainers | MT |
| Capitalization | 3.96B 3.37B 3.11B 2.93B 5.44B 369B 5.53B 36.44B 14.28B 177B 14.87B 14.56B 631B | P/E ratio 2026 * |
12x | P/E ratio 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise value | 3.75B 3.18B 2.94B 2.77B 5.14B 349B 5.23B 34.45B 13.5B 168B 14.06B 13.77B 597B | EV / Sales 2026 * |
3.23x | EV / Sales 2027 * | 2.91x |
| Free-Float |
96.11% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 week | +5.27% | ||
| 1 month | +20.78% | ||
| 3 months | +60.36% | ||
| 6 months | +29.91% | ||
| Current year | +20.90% |
| 1 week | 1,160 | 1,264 | |
| 1 month | 975.5 | 1,264 | |
| 3 years | 554.83 | 2,020 | |
| 5 years | 335 | 2,020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.56% | +5.27% | +49.52% | -20.18% | 3.96B | ||
| -0.11% | -5.36% | +23.01% | +142.78% | 810B | ||
| -1.73% | -2.81% | +52.39% | +41.57% | 575B | ||
| +0.27% | -1.61% | +21.73% | +29.66% | 369B | ||
| -0.59% | +0.48% | +23.57% | +13.94% | 324B | ||
| +0.65% | -2.33% | +44.57% | +24.97% | 311B | ||
| -2.07% | -5.89% | +51.01% | +0.39% | 291B | ||
| -0.78% | -3.10% | +30.18% | +34.27% | 289B | ||
| +0.34% | -1.75% | +23.62% | +40.84% | 188B | ||
| -0.87% | -2.49% | +32.10% | +65.67% | 173B | ||
| Average | -0.47% | -1.53% | +35.17% | +37.39% | 370.04B | |
| Weighted average by Cap. | -0.54% | -1.29% | +33.60% | +57.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.16B 985M 909M 857M 1.59B 108B 1.62B 10.66B 4.18B 51.91B 4.35B 4.26B 185B | 1.22B 1.04B 957M 902M 1.67B 114B 1.7B 11.22B 4.4B 54.65B 4.58B 4.48B 194B |
| Net income | 353M 300M 277M 261M 485M 32.88B 493M 3.25B 1.27B 15.82B 1.33B 1.3B 56.25B | 413M 350M 324M 305M 566M 38.39B 576M 3.79B 1.49B 18.47B 1.55B 1.52B 65.67B |
| Net Debt | -216M -183M -169M -160M -296M -20.09B -301M -1.98B -778M -9.66B -810M -793M -34.36B | -412M -350M -323M -305M -566M -38.38B -575M -3.79B -1.49B -18.47B -1.55B -1.52B -65.66B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INDV Stock
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















